ONCY:NASDAQ
Oncolytics Biotech Inc
$0.60
arrow_downward
-0.32%(-0.0019) 1D
Oct 7, 3:41:15 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.59
High
$0.61
Low
$0.58
Mkt. cap
75.76M
Avg. vol.
1.03M
Volume
608.19K
52-wk high
$1.36
52-wk low
$0.58
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.59
High
$0.61
Low
$0.58
Mkt. cap
75.76M
Avg. vol.
1.03M
Volume
608.19K
52-wk high
$1.36
52-wk low
$0.58
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
AD HOC NEWS
·
16 hours ago
Oncolytics Biotech stock heads toward a November 19 board vote
Stock Titan
·
23 hours ago
Two directors aren't standing for reelection at Oncolytics Biotech (ONCY)'s November 19 meeting.
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com